The cellular autophagy markers Beclin-1 and LC3B-II are increased during reperfusion in fibrillated mouse hearts

Current Pharmaceutical Design

Volumn 19, Issue 39, 2013, Pages 6912-6918

  Meyer, Gregory ^a,b   Czompa, Attila ^a   Reboul, Cyril ^b   Csepanyi, Evelin ^a   Czegledi, Andras ^a   Bak, Istvan ^a   Balla, Gyorgy ^c,d   Balla, Jozsef ^c,d   Tosaki, Arpad ^a   Lekli, Istvan ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF AVIGNON   (France)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Autophagy; Ischemia; Reperfusion; Ventricular fibrillation

Indexed keywords

ATG 12 PROTEIN; ATG 7 PROTEIN; AUTOPHAGY PROTEIN 5; BECLIN 1; CELL PROTEIN; LC3B I PROTEIN; LC3B II PROTEIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ELECTROCARDIOGRAM; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE FIBRILLATION; ISOLATED HEART; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINUS RHYTHM; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BIOLOGICAL MARKERS; BLOTTING, WESTERN; MALE; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MYOCARDIUM; REPERFUSION INJURY;

EID: 84889011698     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161281939131127122510     Document Type: Article

References (73)

1. Ong SB, Gustafsson AB. New roles for mitochondria in cell death in the reperfused myocardium. Cardiovasc Res 2012; 94: 190-6.
2. Zhai P, Sadoshima J. Glycogen synthase kinase-3beta controls autophagy during myocardial ischemia and reperfusion. Autophagy 2012; 8: 138-9.
3. Guarini G, Huqi A, Capozza P, Morrone D, Donati F, Marzilli M. Therapy against ischemic injury. Curr Pharm Des 2012.
4. Moore EM, Nichol AD, Bernard SA, Bellomo R. Therapeutic hypothermia: benefits, mechanisms and potential clinical applications in neurological, cardiac and kidney injury. Injury 2011; 42: 843-54.
5. Hagar JM, Hale SL, Kloner RA. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ Res 1991; 68: 61-8.
6. Koda K, Salazar-Rodriguez M, Corti F, et al. Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. Circulation 2010; 122: 771-81.
7. Fujimatsu T, Nitta T, Osawa H, Shimizu K. Serial changes in epicardial electrograms during and after a coronary artery occlusion. Gen Thorac Cardiovasc Surg 2010; 58: 323-30.
8. de Jong JS, Marsman RF, Henriques JP, et al. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era. Am Heart J 2009; 158: 467-72.
9. Bradley CP, Clayton RH, Nash MP, et al. Human ventricular fibrillation during global ischemia and reperfusion: paradoxical changes in activation rate and wavefront complexity. Circ Arrhythm Electrophysiol 2011; 4: 684-91.
10. Kovacs P, Bak I, Szendrei L, et al. Non-specific caspase inhibition reduces infarct size and improves post-ischaemic recovery in isolated ischaemic/reperfused rat hearts. Naunyn Schmiedebergs Arch Pharmacol 2001; 364: 501-7.
11. Bak I, Czompa A, Juhasz B, Lekli I, Tosaki A. Reduction of reperfusion-induced ventricular fibrillation and infarct size via heme oxygenase-1 overexpression in isolated mouse hearts*. J Cell Mol Med 2010; 14: 2268-2272.
12. Haines D, Juhasz B, Tosaki A. Management of Multicellular Senescence and Oxidative Stress J Cell Mol Med 2013.
13. Oliveira RS, Ferreira JC, Gomes ER, et al. Cardiac antiremodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. J Physiol 2009; 587: 3899-910.
14. McClintock D, Gordon LB, Djabali K. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci U S A 2006; 103: 2154-9.
15. Ikeda Y, Sato K, Pimentel DR, et al. Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction. J Biol Chem 2009; 284: 35839-49.
16. Korac J, Schaeffer V, Kovacevic I, et al. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J Cell Sci 2012.
17. Wang IF, Guo BS, Liu YC, et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci USA 2012; 109: 15024-9.
18. Song CY, Guo JF, Liu Y, Tang BS. Autophagy and Its Comprehensive Impact on ALS. Int J Neurosci 2012; 122: 695-703.
19. Yan L, Vatner DE, Kim SJ, et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 2005; 102: 13807-12.
20. Gurusamy N, Lekli I, Gherghiceanu M, Popescu LM, Das DK. BAG-1 induces autophagy for cardiac cell survival. Autophagy 2009; 5: 120-1.
21. Gurusamy N, Lekli I, Gorbunov NV, Gherghiceanu M, Popescu LM, Das DK. Cardioprotection by adaptation to ischaemia augments autophagy in association with BAG-1 protein. J Cell Mol Med 2009; 13: 373-87.
22. Hoshino A, Matoba S, Iwai-Kanai E, et al. p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia. J Mol Cell Cardiol 2012; 52: 175-84.
23. Valentim L, Laurence KM, Townsend PA, et al. Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J Mol Cell Cardiol 2006; 40: 846-52.
24. Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100: 914-22.
25. Przyklenk K, Dong Y, Undyala VV, Whittaker P. Autophagy as a therapeutic target for ischaemia/reperfusion injury? Concepts, controversies, and challenges. Cardiovasc Res 2012; 94: 197-205.
26. Cesen MH, Pegan K, Spes A, Turk B. Lysosomal pathways to cell death and their therapeutic applications. Exp Cell Res 2012; 318: 1245-51.
27. Lee JS, Kim YJ, Kim CL, Lee GM. Differential induction of autophagy in caspase-3/7 down-regulating and Bcl-2 overexpressing recombinant CHO cells subjected to sodium butyrate treatment. J Biotechnol 2012; 161: 34-41.
28. Xiao R, Teng M, Zhang Q, Shi XH, Huang YS. Myocardial autophagy after severe burn in rats. PLoS One 2012; 7: e39488.
29. Bandyopadhyay U, Kaushik S, Varticovski L, Cuervo AM. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol Cell Biol 2008; 28: 5747-63.
30. Garcia L, Verdejo HE, Kuzmicic J, et al. Impaired cardiac autophagy in patients developing postoperative atrial fibrillation. J Thorac Cardiovasc Surg 2012; 143: 451-9.
31. Chen MC, Chang JP, Wang YH, Liu WH, Ho WC, Chang HW. Autophagy as a mechanism for myolysis of cardiomyocytes in mitral regurgitation. Eur J Clin Invest 2011; 41: 299-307.
32. Bak I, Szendrei L, Turoczi T, et al. Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium. FASEB J 2003; 17: 2133-5.
33. Andre L, Gouzi F, Thireau J, et al. Carbon monoxide exposure enhances arrhythmia after cardiac stress: involvement of oxidative stress. Basic Res Cardiol 2011; 106: 1235-46.
34. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19: 5720-8.
35. Tanida I, Ueno T, Kominami E. Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes. J Biol Chem 2004; 279: 47704-10.
36. Wu J, Dang Y, Su W, et al. Molecular cloning and characterization of rat LC3A and LC3B-two novel markers of autophagosome. Biochem Biophys Res Commun 2006; 339: 437-42.
37. Kabeya Y, Mizushima N, Yamamoto A, Oshitani-Okamoto S, Ohsumi Y, Yoshimori T. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci 2004; 117: 2805-12.
38. Mizushima N, Sugita H, Yoshimori T, Ohsumi Y. A new protein conjugation system in human. The counterpart of the yeast Apg12p conjugation system essential for autophagy. J Biol Chem 1998; 273: 33889-92.
39. Mizushima N, Noda T, Yoshimori T, et al. A protein conjugation system essential for autophagy. Nature 1998; 395: 395-8.
40. Suzuki K, Kirisako T, Kamada Y, Mizushima N, Noda T, Ohsumi Y. The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J 2001; 20: 5971-81.
41. Tanida I, Mizushima N, Kiyooka M, et al. Apg7p/Cvt2p: A novel protein-activating enzyme essential for autophagy. Mol Biol Cell 1999; 10: 1367-79.
42. Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation 1999; 99: 518-28.
43. Said M, Becerra R, Valverde CA, et al. Calcium-calmodulin dependent protein kinase II (CaMKII): a main signal responsible for early reperfusion arrhythmias. J Mol Cell Cardiol 2011; 51: 936-44.
44. Stables CL, Curtis MJ. Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation. Cardiovasc Res 2009; 83: 397-404.
45. Charniot JC, Vignat N, Albertini JP, et al. Oxidative stress in patients with acute heart failure. Rejuvenation Res 2008; 11: 393-8.
46. Volk T, Schmutzler M, Engelhardt L, et al. Effects of different steroid treatment on reperfusion-associated production of reactive oxygen species and arrhythmias during coronary surgery. Acta Anaesthesiol Scand 2003; 47: 667-74.
47. Luther S, Fenton FH, Kornreich BG, et al. Low-energy control of electrical turbulence in the heart. Nature 2011; 475: 235-9.
48. Szendrei L, Turoczi T, Kovacs P, Vecsernyes M, Das DK, Tosaki A. Mitochondrial gene expression and ventricular fibrillation in ischemic/reperfused nondiabetic and diabetic myocardium. Biochem Pharmacol 2002; 63: 543-52.
49. Giudicessi JR, Ackerman MJ. Potassium-channel mutations and cardiac arrhythmias-diagnosis and therapy. Nat Rev Cardiol 2012; 9: 319-32.
50. Belevych AE, Terentyev D, Terentyeva R, et al. Shortened Ca2+ signaling refractoriness underlies cellular arrhythmogenesis in a postinfarction model of sudden cardiac death. Circ Res 2012; 110: 569-77.
51. Hsieh YC, Athar M, Chaudry IH. When apoptosis meets autophagy: deciding cell fate after trauma and sepsis. Trends Mol Med 2009; 15: 129-38.
52. Itakura E, Mizushima N. Atg14 and UVRAG: mutually exclusive subunits of mammalian Beclin 1-PI3K complexes. Autophagy 2009; 5: 534-6.
53. Chang YY, Juhasz G, Goraksha-Hicks P, et al. Nutrient-dependent regulation of autophagy through the target of rapamycin pathway. Biochem Soc Trans 2009; 37: 232-6.
54. Sciarretta S, Hariharan N, Monden Y, Zablocki D, Sadoshima J. Is autophagy in response to ischemia and reperfusion protective or detrimental for the heart? Pediatr Cardiol 2011; 32: 275-81.
55. Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011; 18: 571-80.
56. Salminen A, Kaarniranta K, Kauppinen A. Beclin 1 interactome controls the crosstalk between apoptosis, autophagy and inflammasome activation: Impact on the aging process. Ageing Res Rev 2012.
57. Noda T, Fujita N, Yoshimori T. The late stages of autophagy: how does the end begin? Cell Death Differ 2009; 16: 984-90.
58. Haines DD, Bak I, Ferdinandy P, et al. Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol 2000; 35: 37-44.
59. Szabo G, Farkas V, Grunnet M, Mohacsi A, Nanasi PP. Enhanced repolarization capacity: new potential antiarrhythmic strategy based on HERG channel activation. Curr Med Chem 2011; 18: 3607-21.
60. Csonka C, Onody A, Csont T, Ferdinandy P. Defibrillatory action of glibenclamide is independent from ATP-sensitive K+ channels and free radicals. J Cardiovasc Pharmacol 2003; 41: 916-22.
61. Tominaga M, Horie M, Sasayama S, Okada Y. Glibenclamide, an ATP-sensitive K+ channel blocker, inhibits cardiac cAMPactivated Cl-conductance. Circ Res 1995; 77: 417-23.
62. Caimmi PP, Molinari C, Uberti F, et al. Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide. Eur J Cardiothorac Surg 2011; 39: e59-67.
63. Carchman EH, Rao J, Loughran PA, Rosengart MR, Zuckerbraun BS. Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice. Hepatology 2011; 53: 2053-62.
64. Unuma K, Aki T, Matsuda S, Funakoshi T, Yoshida K, Uemura K. Inducer of heme oxygenase-1 cobalt protoporphyrin accelerates autophagy and suppresses oxidative damages during lipopolysaccharide treatment in rat liver. Hepatol Res 2013; 43: 91-6.
65. Haines DD, Lekli I, Teissier P, Bak I, Tosaki A. Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies: focus on cardiovascular, lung, neurological and kidney disorders. Acta Physiol (Oxf) 2012; 204: 487-501.
66. Kikuchi G, Yoshida T, Noguchi M. Heme oxygenase and heme degradation. Biochem Biophys Res Commun 2005; 338: 558-67.
67. Mohri T, Ogura H, Koh T, et al. Enhanced expression of intracellular heme oxygenase-1 in deactivated monocytes from patients with severe systemic inflammatory response syndrome. J Trauma 2006; 61: 616-23; discussion 623.
68. Jonas JC, Guiot Y, Rahier J, Henquin JC. Haeme-oxygenase 1 expression in rat pancreatic beta cells is stimulated by supraphysiological glucose concentrations and by cyclic AMP. Diabetologia 2003; 46: 1234-44.
69. Ndisang JF, Zhao W, Wang R. Selective regulation of blood pressure by heme oxygenase-1 in hypertension. Hypertension 2002; 40: 315-21.
70. Ndisang JF, Masini E, Mannanoni PF, Wang R. Carbon Monoxide and Cardiovascular Inflammation. In: Wang R, ed. Carbon Monoxide and Cardiovascular Functions. CPC Press: Boca Raton 2001; pp. 165-180.
71. Szabo ME, Gallyas E, Bak I, et al. Heme oxygenase-1-related carbon monoxide and flavonoids in ischemic/reperfused rat retina. Invest Ophthalmol Vis Sci 2004; 45: 3727-32.
72. Bak I, Varadi J, Nagy N, Vecsernyes M, Tosaki A. The role of exogenous carbon monoxide in the recovery of post-ischemic cardiac function in buffer perfused isolated rat hearts. Cell Mol Biol (Noisy-le-grand) 2005; 51: 453-9.
73. Pataki T, Bak I, Csonka C, et al. Regulation of ventricular fibrillation by heme oxygenase in ischemic/reperfused hearts. Antioxid Redox Signal 2001; 3: 125-34.